Influenza: Recommended vaccinations
Back to search
Export to spreadsheet
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
WeeksMonthsYears
667-2324567121315161718455455596064≥ 65
Austria
IIV1
IIV2
Belgium
IIV43
IIV44
Bulgaria
IIV5
Croatia
IIV46
IIV47
Cyprus
IIV38
IIV38
IIV39
Czech Republic
IIV410
IIV411
Denmark
IIV412
Estonia
IIV
IIV
Finland
IIV/LAIV13
IIV4
France
LAIV
IIV4
Germany
IIV414
Greece
IIV3
IIV3
Hungary
IIV3
Iceland
IIV415
Ireland
IIV4/LAIV16
IIV417
IIV418
Italy
IIV319
IIV3
Latvia
IIV4
IIV4/LAIV20
IIV
Liechtenstein
IIV321
Lithuania
IIV322
Luxembourg
IIV4
Malta
IIV323
IIV3
Netherlands
IIV424
Norway
IIV425
IIV4
Poland
IIV3
IIV3
Portugal
IIV3
Romania
IIV3
Slovakia
IIV3
IIV3
Slovenia
IIV426
IIV427
IIV4
Spain
IIV28
IIV29
IIV14
Sweden
IIV330
IIV3

Footnotes:

  1. Initial vaccination consists of 2 doses 4 weeks apart until 9 years, thereafter annual vaccination recommended
  2. Announcement on the 2023/24 influenza campaign will be available here: https://www.sozialministerium.at/Themen/Gesundheit/Impfen/Influenza-Impfung/%C3%96ffentliches-Impfprogramm-Influenza.html
  3. For individuals with certain medical conditions or a weakened immune system, which may put them at risk of complications from influenza (from 6 months and over). For pregnant women in the second or third trimester of pregnancy at the time of the influenza season. For healthcare workers. For institutionnalised persons. For persons living under the same roof as individual at risk of complications from influenza (including pregnant women, institutionnalised persons and people aged 65 years and over) en children less than 6 months. https://www.vaxinfopro.be/spip.php?rubrique28&lang=fr&retour=1
  4. https://www.health.belgium.be/fr/avis-9699-vaccination-grippe-saisonniere-saison-hivernale-2022-2023
  5. Annual vaccination. Recommended but not free of charge.
  6. Recommended for risk-groups only
  7. IIV4 recommended for high-risk individuals.https://www.hzjz.hr/sluzba-epidemiologija-zarazne-bolesti/pocinje-cijepljenje-protiv-gripe-za-sezonu-2020-2021/
  8. Vaccines only given on specific indications.
  9. annual vaccination
  10. For at-risk groups of any age. Recommended only. The vaccination is covered by the health insurance. In addition, there is a general recommendation for whole population. This vaccination is not covered by the health insurance.
  11. Recommended only. The vaccination is covered by the health insurance.
  12. https://www.ssi.dk/vaccinationer/influenzavaccination The InfluvacTetra vaccine may be used for vaccination of children as from three years of age, whereas the VaxigripTetra is approved for use in children as from six months of age. In addition, a third influenza vaccine, Fluzone, which is a high-dose 3-valent vaccine, will be used. Fluzone is available to a limited extent and will be offered to citizens aged 85 or above, as this vaccine is considered more effective for the oldest age groups compared to the two 4-valent standard-dose vaccines
  13. more information available at https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/influenssarokote/kenelle-ilmainen-influenssarokote-/alle-7-vuotiaiden-lasten-influenssarokotukset
  14. Annual vaccination
  15. Annual vaccination (IIV4 introduced in 2020 to replace IIV3)
  16. LAIV is recommended in children aged 2-17 year-old. https://www.hse.ie/eng/health/immunisation/pubinfo/flu-vaccination/flu-vaccine-for-children/ https://www.hse.ie/eng/health/immunisation/hcpinfo/fluinfo/
  17. Flu vaccine is strongly recommended for pregnant women (vaccine can be given at any stage of pregnancy), adults and children aged 6 months and older with specific conditions. More information available at: https://www.hse.ie/eng/health/immunisation/pubinfo/flu-vaccination/flu-vaccine-for-people-with-long-term-conditions/
  18. The vaccine is free of charge, but administration fees may be charged to patient (based on income and eligibility for free healthcare)
  19. For individuals at increased risk. More information available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
  20. Vaccination against influenza in children aged 2 to 18 years who belong to the following health risk groups: children with chronic lung diseases, chronic cardiovascular diseases regardless of their cause, chronic metabolic diseases, chronic kidney diseases, children with immunodeficiency, children receiving immunosuppressants therapy, who receive long-term therapy with ac. acetylsalicylic acid.
  21. Annual vaccination.
  22. Annual vaccination for risk groups: healthcare workers, pregnant women, >=65 years old, persons <65 years with chronic diseases and/or living in social care and nurse facilities.
  23. more information available at https://deputyprimeminister.gov.mt/en/phc/pchyhi/Pages/Vaccines.aspx . Vaccination recommended to persons suffering from diabetes; persons with chronic disease of the lungs, liver, kidneys; persons who are on long-term systemic steroid medication; persons who are having chemotherapy or radiotherapy; persons with HIV/AIDS.
  24. https://www.rivm.nl/en/flu-and-flu-jab
  25. Both quadrivalent inactivated injection vaccine (IIV, from 6 months of age) and live attenuated influenza vaccine (LAIV, from 2 to 17 years of age) are approved for use in Norway. More information on groups in which vaccination is recommended is available at: https://www.fhi.no/nettpub/vaksinasjonsveilederen-for-helsepersonell/vaksiner-mot-de-enkelte-sykdommene/influensavaksinasjon---veileder-for/
  26. Children 6-23 months, recommended, self-paid
  27. Pregnant women
  28. Additional information available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/Recomendaciones_vacunacion_gripe_PoblacionInfantil.pdf
  29. Recommended for children and adults with high risk conditions. Additional information available: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/Recomendaciones_vacunacion_gripe.pdf
  30. Funding varies by region